David Sefrioui

Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)

Fanny Garlan, Pierre Laurent‐Puig, David Sefrioui et al. · Clinical Cancer Research · 2017 · 243 citations · Full text

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 163 citations · Full text

Solid Cancer Patients, Cancer Epidemiology, Disease Risk Assessment +12

Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study

David Tougeron, Guillaume Mouillet, Isabelle Trouilloud et al. · JNCI Journal of the National Cancer Institute · 2016 · 156 citations · Full text

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours

David Sefrioui, France Blanchard, Emmanuel Touré et al. · British Journal of Cancer · 2017 · 116 citations · Full text

Kinetics, prognostic and predictive values of <i>ESR1</i> circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor

Florian Clatot, Anne Perdrix, Laetitia Augusto et al. · Oncotarget · 2016 · 95 citations · Full text